Affymetrix and Beckman Coulter Join Forces to Provide Automated Target Preparation Solutions
News Sep 02, 2009
Affymetrix, Inc. and Beckman Coulter, Inc. have announced that they have entered into an agreement to offer researchers co-developed products in microarrays and automated liquid handlers. The collaboration will provide scientists with optimized, robust solutions for genomic research, fortified by end-to-end support.
The partnership will yield an expanding list of Affymetrix-validated automated target preparation methods, developed on an Affymetrix-specific configuration of Beckman Coulter’s Biomek FXp Dual Arm Multichannel–Span 8 Liquid Handler. This platform will provide researchers with standardized systems that include all components necessary to run Affymetrix genotyping and gene expression assays.
Major benefits of the solution will include the flexibility to process samples using Affymetrix GeneChip® Arrays or Array Plates with a single method, user-friendly interfaces, implementation of new methods, a validated platform and delivery of high-quality results.
Automated target preparation solutions from Affymetrix and Beckman Coulter are for research use only and are not for use in diagnostic procedures.
The Biomek FXp Dual Arm Multichannel–Span 8 Liquid Handler is for laboratory use only and not for use in diagnostic procedures.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE
Artificial Cellular Compartments BuiltNews
How to install new capabilities in cells without interfering with their metabolic processes? A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have altered mammalian cells in such a way that they formed artificial compartments in which sequestered reactions could take place, allowing the detection of cells deep in the tissue and also their manipulation with magnetic fields.READ MORE